Research Links

MURFREESBORO — Paralyzed from the waist down since a freak mowing accident in June 2007, Carmen Thompson is taking some groundbreaking steps — even if they're in water.

Her husband, Terry, a general contractor, has made their Nashville home...

David Cooper/TORONTO STAR file photo
 Barbara Turnbull
 Life Reporter

Canadians vastly underestimate the human and financial cost of spinal cord injury, according to new statistics from the Rick Hansen Institute.

In a survey conducted for RHI by Angus Reid, Canadians were asked to estimate annual costs associated with spinal cord injuries, the unemployment...

BEIJING — The Health Ministry ordered unapproved stem cell treatments stopped Tuesday as China tries to bring under control its growing but loosely regulated industry.

The ministry stopped accepting applications for stem cell procedures until July and is implementing a yearlong campaign to halt unauthorized stem cell therapy trials...

CEO to Discuss the Company's Latest Advances in Spinal Cord Injury Treatment on January 11th 

CAMBRIDGE, Mass., Jan 10, 2012 (BUSINESS WIRE) -- InVivo Therapeutics Holdings Corp. /quotes/zigman/625813 NVIV -4.78% , a developer of groundbreaking technologies for the treatment of spinal cord injuries (SCI), today..

By Stuart Wolpert January 05, 2012 Category: Academics & Faculty, Health Sciences, Research
 
V. Reggie EdgertonV. Reggie Edgerton, UCLA distinguished professor of integrative biology and physiology and of neurobiology; Yury Gerasimenko, professor and director of the laboratory of movement physiology at St. Petersburg's Pavlov Institute and a researcher in UCLA’s Department of Integrative Biology and Physiology; and colleagues have been awarded a Popular Mechanics' 2011 Breakthrough Award for developing "an electric therapy that stimulates spinal nerves, allowing the paralyzed to walk." Edgerton, Gerasimenko and their...

NEWARK, Calif., Dec 15, 2011 (GlobeNewswire via COMTEX) -- StemCells, Inc. /quotes/zigman/5728491/quotes/nls/stem STEM -5.99% announced today that the first cohort of the Company's Phase I/II clinical trial in chronic spinal cord injury have been successfully transplanted with the Company's proprietary HuCNS-SC(R) neural stem cells. This landmark clinical trial has a unique design..

Julia Prodis Sulek

Katie Sharify, 23, of Pleasanton, does physical therapy in the spinal cord.  Paralyzed from the torso down, Katie Sharify heads home from Santa Clara Valley Medical Center on Wednesday, daring to hope that the 2 million stem cells creeping up her damaged...

Teeth could hold the key to helping spinal cord injury victims to walk again.

Scientists transplanted dental pulp stem cells into rats with broken backs and discovered the animals regained some leg movement.

It appeared the dental pulp, found in the ...

The biotech Geron may have abandoned its famous effort to treat paralyzed patients with stem cells—but two rivals are swooping in to do groundbreaking trials, Sharon Begley reports. So far, their results are even more promising...

TRENTON, N.J. – The company doing the first government-approved test of embryonic stem cell therapy is discontinuing further stem cell work, a move with stark implications for a field offering hope of future medicines for conditions with inadequate or no current treatments...